Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Samel Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korean Society of Nephrology, Soonchunhyang University, National Research Foundation of Korea.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
The early clinical impact of type 2 diabetes is not fully understood due to uncertainties surrounding the timing of disease onset. We assessed clinical outcomes in patients newly diagnosed with type 2 diabetes and without preexisting comorbidities, utilising the Korean National Health Insurance Service database. Materials and Methods We identified patients (20–80 years) newly diagnosed with type 2 diabetes without prior atherosclerotic cardiovascular or kidney disease (eGFR < 60 mL/min/1.73 m 2 , albuminuria, or relevant ICD codes). Age‐ and sex‐matched controls were selected (1:4). Primary outcomes included ischemic/hemorrhagic stroke, myocardial infarction, heart failure, chronic kidney disease (CKD) progression to eGFR < 60 mL/min/1.73 m 2 , renal replacement therapy (RRT), and all‐cause mortality.
Results
Among 2 164 060 individuals, 432 812 were newly diagnosed with type 2 diabetes. Participants were followed for a median of 5.1 years (IQR 3.3–6.2 years; maximum follow‐up 7.6 years). After adjusting for covariates, the risks in the type 2 diabetes group remained significantly elevated compared to the controls: total composite outcome (hazard ratio, HR [95% confidence interval, CI]: 1.67 [1.64–1.70]), non‐renal composite outcome (1.57 [1.53–1.60]), renal composite outcome (1.86 [1.82–1.90]), and individual outcomes including ischemic stroke (1.73 [1.66–1.80]), hemorrhagic stroke (1.24 [1.14–1.35]), myocardial infarction (1.84 [1.73–1.95]), heart failure (2.17 [2.08–2.27]), CKD progression (1.47 [1.41–1.53]), RRT (4.17 [3.51–4.95]), and all‐cause mortality (1.14 [1.10–1.19]).
Conclusions
Patients newly diagnosed with type 2 diabetes faced substantially increased risks of cardiovascular, renal complications, and all‐cause mortality, despite preserved baseline kidney function. Proactive risk assessments and preventive strategies are needed to mitigate the long‐term burden of diabetes‐related complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.
- Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Korea.
- Division of Nephrology and Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
- Department of Internal Medicine-Nephrology, Inje University, Ilsan-Paik Hospital, Goyang, Korea.
ORCID-Profile: Samel Park, Hyun Jung Kim, Hyung Woo Kim, Sun-Hee Park, Sang Youb Han
Förderung
- Korean Society of Nephrology
- Soonchunhyang University
- National Research Foundation of Korea
Zitieren
APA
Park, S., Kim, H. J., Kim, H. W., Park, S. H., & Han, S. Y. (2026). Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71116
Vancouver
Park S, Kim HJ, Kim HW, Park SH, Han SY. Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71116
BibTeX
@article{Park2026,
author = {Park, Samel and Kim, Hyun Jung and Kim, Hyung Woo and Park, Sun-Hee and Han, Sang Youb},
title = {Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71116}
}
EUVIMED